154.51
Align Technology Inc stock is traded at $154.51, with a volume of 897.39K.
It is down -0.64% in the last 24 hours and up +4.28% over the past month.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
See More
Previous Close:
$155.51
Open:
$154.79
24h Volume:
897.39K
Relative Volume:
0.96
Market Cap:
$10.98B
Revenue:
$4.10B
Net Income/Loss:
$429.89M
P/E Ratio:
25.89
EPS:
5.9668
Net Cash Flow:
$583.65M
1W Performance:
+4.89%
1M Performance:
+4.28%
6M Performance:
-18.96%
1Y Performance:
+13.61%
Align Technology Inc Stock (ALGN) Company Profile
Name
Align Technology Inc
Sector
Industry
Phone
408-470-1000
Address
410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE, CA
Compare ALGN vs ISRG, BDX, RMD, ALC, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ALGN
Align Technology Inc
|
154.51 | 10.98B | 4.10B | 429.89M | 583.65M | 5.9668 |
|
ISRG
Intuitive Surgical Inc
|
452.29 | 159.78B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
198.91 | 54.18B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
RMD
Resmed Inc
|
252.86 | 35.56B | 5.54B | 1.52B | 1.74B | 10.37 |
|
ALC
Alcon Inc
|
70.17 | 33.92B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
34.09 | 29.91B | 29.14B | 1.07B | 1.05B | 1.1956 |
Align Technology Inc Stock (ALGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-05-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Jul-09-26 | Initiated | BMO Capital Markets | Outperform |
| Apr-15-26 | Initiated | Citigroup | Buy |
| Mar-17-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Feb-09-26 | Upgrade | HSBC Securities | Hold → Buy |
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Oct-10-25 | Downgrade | Jefferies | Buy → Hold |
| Jul-31-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-25-25 | Downgrade | HSBC Securities | Buy → Hold |
| Feb-14-25 | Initiated | Wells Fargo | Overweight |
| Jan-06-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Oct-10-24 | Initiated | Needham | Hold |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-11-23 | Downgrade | Goldman | Neutral → Sell |
| Oct-27-23 | Downgrade | UBS | Buy → Neutral |
| Feb-02-23 | Upgrade | Goldman | Sell → Neutral |
| Jul-28-22 | Downgrade | Goldman | Buy → Sell |
| Jan-31-22 | Initiated | Morgan Stanley | Overweight |
| Jan-31-22 | Upgrade | UBS | Neutral → Buy |
| Oct-01-21 | Resumed | Credit Suisse | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-09-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Jul-08-21 | Initiated | Exane BNP Paribas | Outperform |
| Apr-22-21 | Upgrade | Berenberg | Hold → Buy |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-29-20 | Downgrade | Berenberg | Buy → Hold |
| Jul-20-20 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-09-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-24-19 | Reiterated | BofA/Merrill | Neutral |
| Oct-07-19 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-25-19 | Downgrade | Evercore ISI | Outperform → In-line |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Feb-14-19 | Downgrade | UBS | Buy → Neutral |
| Jan-17-19 | Initiated | UBS | Buy |
| Nov-20-18 | Reiterated | Credit Suisse | Outperform |
| Jul-26-18 | Reiterated | Stifel | Buy |
| Jul-13-18 | Reiterated | Stifel | Buy |
| Jun-25-18 | Resumed | BofA/Merrill | Buy |
| May-22-18 | Reiterated | Stifel | Buy |
| May-17-18 | Initiated | Evercore ISI | Outperform |
| Apr-26-18 | Reiterated | Stifel | Buy |
| Apr-20-18 | Initiated | Berenberg | Buy |
| Apr-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-08-18 | Initiated | Barclays | Overweight |
View All
Align Technology Inc Stock (ALGN) Latest News
Align Technology to Report Q3 Earnings: What's in the Cards? - Zacks Investment Research
Align Technology to Report Q3 Earnings: What's in the Cards? - Yahoo Finance
US court revives antitrust claims against Align Technology - Dental Tribune US
Align Technology, Inc. (ALGN) Stock Forecasts - Yahoo Finance
Align Technology, Inc. (ALGN) options chain - Yahoo Finance Australia
Piper Sandler cuts Align Technology stock price target on volume decline By Investing.com - Investing.com South Africa
Align Technology Is Maintained at Overweight by Piper Sandler - Moomoo
Align Technology (ALGN) Earnings Expected to Grow: Should You Buy? - Yahoo Finance Singapore
Piper Sandler Adjusts Price Target on Align Technology to $205 From $235 - Yahoo Finance
Align Technology Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Baird downgrades Align Technology stock to Neutral at USD 162 - ad-hoc-news.de
What You Need To Know Ahead of Align Technology's Earnings Release - Yahoo Finance
Align Technology Inc. stock outperforms competitors on strong trading day - MarketWatch
Align Technology notches another win in escalating clear aligner feud - Life Sciences IP Review
Align Technology Wins Patent Infringement Case Against Angelalign - marketscreener.com
Align Technology (ALGN) Wins European Patent Infringement Ruling Against Angelalign - GuruFocus
Align Technology says European court finds Angelalign infringed patent (ALGN:NASDAQ) - Seeking Alpha
Align Technology (ALGN) Wins European Patent Ruling Against Ange - GuruFocus
Align Technology, Inc. (ALGN) Options Chain - Yahoo! Finance Canada
Align Technology Wins Significant Patent Infringement Case Against Angelalign at Unified Patent Court - Business Wire
Align Technology Wins Significant Patent Infringement Case Against Angelalign at Unified Patent Court - FinancialContent
Align Technology Inc. stock underperforms Friday when compared to competitors - MarketWatch
Align Technology Inc. stock outperforms competitors on strong trading day - MarketWatch
Align Technology, Inc. (ALGN) Stock forecasts - Yahoo Finance Australia
This Align Technology Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga
Align Technology, Inc. (ALGN) Stock Forecasts - Yahoo Finance
ANTITRUST—9th Cir.: Invisalign® manufacturer must face refusal to deal allegations (Oct 6, 2026) - VitalLaw.com
9th Circ. Revives Antitrust Suits Against Invisalign - Law360
Federal Appeals Court Reverses Ruling Against Align Technology (ALGN), Raising Antitrust Concerns - GuruFocus
Align Technology Inc. stock underperforms Monday when compared to competitors - MarketWatch
Align Technology hit as appeals court revives dental aligners antitrust claims - TradingView
CPI | Invisalign Maker Must Face Renewed Antitrust Litigation - PYMNTS.com
Align Technology Slides After Downgrade Points to Softer Demand - Quiver Quantitative
Evercore cuts target for Align Technology stock from USD 220 to USD 155 - AD HOC NEWS
Here Are Monday’s Top Wall Street Analyst Research Calls: Align Technology, AutoNation, Estee Lauder, Harley-Davidson, HubSpot, Microsoft, Mosaic, Ryder System, Wells Fargo & Company, and More - Yahoo Finance
Here Are Monday’s Top Wall Street Analyst Research Calls: Align Technology, AutoNation, Estee Lauder, Harley-Davidson, HubSpot, Microsoft, Mosaic, Ryder System, Wells Fargo & Company, and More - 24/7 Wall St.
Align Technology, Group 1 Automotive And Other Big Stocks Moving Lower In Monday’s Pre-Market Session - Benzinga
Why is Align Technology stock sliding 2% today? - Investing.com
Evercore ISI cuts Align Technology stock rating on weak demand By Investing.com - Investing.com Canada
Align Technology Shares Fall After Evercore ISI Downgrades Stock - Yahoo Finance
Evercore ISI Downgrades Align Technology to In Line From Outperform - marketscreener.com
Can Product Adoption Revive the Story at Align Technology (NASDAQ:ALGN)? - kalkinemedia.com
Align Technology (ALGN) Stock Looks Reasonable Even After A 78% Fall - Yahoo Finance
Align Technology Inc. stock underperforms Friday when compared to competitors - MarketWatch
Align Technology Inc. stock underperforms Friday when compared to competitors - MarketWatch
Is Align Technology (ALGN) Undervalued As Its October 28 Earnings Date Nears? - Yahoo Finance
Will Align Technology (ALGN) Beat Estimates Again in Its Next Earnings Report? - Zacks Investment Research
Will Align Technology (ALGN) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar - Zacks Investment Research
Align Technology sets October 28 results. Align Technology stock is 27.49 percent below high - AD HOC NEWS
Align Technology Inc Stock (ALGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Align Technology Inc Stock (ALGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SIEGEL SUSAN E | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
10,723 |
| Saia Andrea Lynn | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
17,318 |
| Poul Mojdeh | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
3,553 |
| Myong Anne | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
9,830 |
| LARKIN C RAYMOND JR | Director |
May 20 '26 |
Option Exercise |
0.00 |
2,326 |
0 |
27,454 |
| Dallas Kevin J | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
16,168 |
| LACOB JOSEPH | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
135,916 |
| Conroy Kevin T | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
3,553 |
| MORROW GEORGE J | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
5,036 |
| Morici John | EVP, CHIEF FINANCIAL OFFICER |
Feb 20 '26 |
Option Exercise |
0.00 |
7,848 |
0 |
16,085 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):